Skip to main content

Find Clinical Trials

Home
Conditions
Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8

Clinical trial condition

Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8

Explore clinical trials studying Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 trial results

Active, Not Recruiting

Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer

NCT04285671

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details